Pacific Biosciences Of California | PACB - Net Income


Pacific Biosciences Of California reported $-40.37M in Net Income for its fiscal quarter ending in December of 2025.





Net Income Change Date
Agilent USD 305M 129M Dec/2025
Bruker USD 26M 88.4M Dec/2025
Danaher USD 1.2B 289M Dec/2025
General Electric Aerospace USD 2.54B 384M Dec/2025
Illumina USD 334M 184M Dec/2025
Myriad Genetics USD -7.9M 19.5M Dec/2025
Pacific Biosciences Of California USD -40.37M 2.37M Dec/2025
Quidel USD -733M 477.6M Sep/2025
Revvity USD 98.36M 51.71M Dec/2025
Roche Holding CHF 5.47B 1.76B Dec/2025
Standard Biotools USD 19.28M 53.97M Dec/2025
Thermo Fisher Scientific USD 1.96B 348M Dec/2025
Waters USD 225.21M 76.29M Dec/2025